• Publications
  • Influence
Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
BACKGROUND Platinum-based therapy, including cisplatin, carboplatin, oxaliplatin or a combination of these, is used to treat a variety of paediatric malignancies. One of the most important adverseExpand
  • 43
  • 2
Platinum-induced hearing loss after treatment for childhood cancer.
BACKGROUND Platinum-based therapy, including cisplatin, carboplatin, oxaliplatin or a combination of these, is used to treat a variety of paediatric malignancies. Unfortunately, one of the mostExpand
  • 17
Different infusion durations for preventing platinum-induced hearing loss in children with cancer.
BACKGROUND Platinum-based therapy, including cisplatin, carboplatin or oxaliplatin, or a combination of these, is used to treat a variety of paediatric malignancies. Unfortunately, one of the mostExpand
  • 10
Guidance regarding COVID‐19 for survivors of childhood, adolescent, and young adult cancer: A statement from the International Late Effects of Childhood Cancer Guideline Harmonization Group
Childhood, adolescent, and young adult (CAYA) cancer survivors may be at risk for a severe course of COVID‐19. Little is known about the clinical course of COVID‐19 in CAYA cancer survivors, or ifExpand
  • 3
Different infusion durations for preventing platinum-induced hearing loss in children with cancer.
BACKGROUND Platinum-based therapy, including cisplatin, carboplatin or oxaliplatin, or a combination of these, is used to treat a variety of paediatric malignancies. Unfortunately, one of the mostExpand
  • 1
Methotrexate for high-grade osteosarcoma in children and young adults.
BACKGROUND The majority of the currently used treatment protocols for osteosarcoma are based on a combination of doxorubicin, cisplatin, methotrexate (MTX) and/or ifosfamide, of which MTX seems to beExpand
  • 1
Different infusion durations for preventing platinum-induced hearing loss in children with cancer.
BACKGROUND Platinum-based therapy, including cisplatin, carboplatin or oxaliplatin, or a combination of these, is used to treat a variety of paediatric malignancies. Unfortunately, one of the mostExpand
Different infusion durations for preventing platinum-induced hearing loss in children with cancer.
BACKGROUND Platinum-based therapy, including cisplatin, carboplatin or oxaliplatin, or a combination of these, is used to treat a variety of paediatric malignancies. Unfortunately, one of the mostExpand
Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
BACKGROUND Platinum-based therapy, including cisplatin, carboplatin, oxaliplatin or a combination of these, is used to treat a variety of paediatric malignancies. One of the most significant adverseExpand